These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14720385)

  • 1. [Abnormalities of molecular biology in premalignant lung lesions].
    Shao SJ; Wang Y; Yang PM
    Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
    Nishisaka T; Takeshima Y; Inai K
    Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T; Takahashi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
    Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
    Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical detection of lung cancer progression markers.
    Tockman MS
    J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.
    Niklinski J; Niklinska W; Chyczewski L; Becker HD; Pluygers E
    Eur J Cancer Prev; 2001 Jun; 10(3):213-26. PubMed ID: 11432708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genomic alterations in preneoplastic lesions].
    Gemma A
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2451-7. PubMed ID: 12506466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From dysplasia to cancer: cytologic, histopathologic and molecular aspects].
    Vignaud JM
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S107-11. PubMed ID: 10088273
    [No Abstract]   [Full Text] [Related]  

  • 10. The biology of lung cancer including potential clinical applications.
    Zöchbauer-Müller S; Minna JD
    Chest Surg Clin N Am; 2000 Nov; 10(4):691-708. PubMed ID: 11091920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic alteration in lung cancer].
    Hashimoto T; Hayashi M; Tsuchiya E
    Nihon Rinsho; 2002 May; 60 Suppl 5():78-82. PubMed ID: 12101778
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
    Tang X; Liu D; Shishodia S; Ozburn N; Behrens C; Lee JJ; Hong WK; Aggarwal BB; Wistuba II
    Cancer; 2006 Dec; 107(11):2637-46. PubMed ID: 17078054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour biology: senescence in premalignant tumours.
    Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M
    Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung cancer].
    Haugen A
    Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2362-5. PubMed ID: 9691805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-step evolution of lung cancer.
    Braithwaite KL; Rabbitts PH
    Semin Cancer Biol; 1999 Aug; 9(4):255-65. PubMed ID: 10448113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular cytopathology of lung cancer--prevalence of genetic alterations and their role in the development of molecular biomarkers].
    Grote HJ; Schmiemann V; Böcking A
    Verh Dtsch Ges Pathol; 2003; 87():142-9. PubMed ID: 16888906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.
    Massion PP; Carbone DP
    Respir Res; 2003; 4(1):12. PubMed ID: 14641911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology of lung cancer].
    Akita H
    Nihon Kokyuki Gakkai Zasshi; 2004 May; 42(5):378-86. PubMed ID: 15168453
    [No Abstract]   [Full Text] [Related]  

  • 20. [New molecular targets in pancreatic cancer].
    Torrisani J; Bournet B; Cordelier P; Buscail L
    Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.